The Action of Neuroleptic Drugs on Dopamine-Stimulated Adenosine Cyclic 3',5'-Monophosphate Production in Rat Neostriatum and Limbic Forebrain

Neuroleptic drugs of various types were more potent inhibitors of dopamine-sensitive production of adenosine cyclic 39,59-monophosphate in homogenates of rat brain striatum than non-neuroleptic drugs of similar structures. The most potent drugs were phenothiazines and thioxanthenes with a -CF3 group in position 2 of the tricyclic system and a piperazino side chain. There were also large differences in the effects of cis and trans isomers of thioxanthenes in which the 2-substituent and the side chain are on the same or opposite side of the double bond connecting the side chain to the ring system. Thus α-flupenthixol, α-clopenthixol, and α-chlorprothixene, which are the cis isomers, were considerably more potent than the corresponding β-isomers of the same drugs. α-Flupenthixol was also considerably more potent than the β-isomer in antagonizing the effect of dopamine on cyclic AMP production in the olfactory tubercle and nucleus accumbens, and in antagonizing the potent dopamine agonist 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene in the striatum. These results are discussed in relation to the hypothesis that neuroleptic activity may be related to the blockade of dopamine receptors in the central nervous system.

• Publication year

  1974

• Venue

  Molecular Pharmacology

• Publication date

  1974-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/s0026-895x(25)13988-6
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Leslie Lars Iversen. 31 October 1937—30 July 2020

  2023cites this paper
• Astrocytes in Cocaine Addiction and Beyond

  2021cites this paper
• Pimozide: A Review of Its Pharmacological Properties and Therapeutic Uses in Psychiatry

  2012cites this paper
• The History of Neuroscience in AutobiographyVolume 7

  2011cites this paper
• Ş izofrenide Serotonin Hipotezi ve

  2010cites this paper
• Neuroleptic blockade of the effect of various neurotransmitter substances.

  2009cites this paper
• Leslie L. Iversen

  2009cites this paper
• The pharmacology of a new potent, long acting neuroleptic, piflutixol.

  2009cites this paper
• Properties of Dopamine Receptors at a Neuroglandular Synapse

  2008cites this paper
• Dopamine: 50 years in perspective.

  2007cites this paper
• Altered sensitivity of f3-adrenoceptor-mediated cyclic AMP formation in brain

  2006influential citation
• Plasma protein binding of propranolol in disease states 0

  2006cites this paper
• Antipsychotic drugs and dopamine-mediated responses in Aplysia neurons

  2005cites this paper
• Mesolimbic dopamine function is not altered during continuous chronic treatment of rats with typical or atypical neuroleptic drugs

  2005cites this paper
• Characterization of binding of3H-SCH 23390 to dopamine D-1 receptors. Correlation to other D-1 and D-2 measures and effect of selective lesions

  2005cites this paper
• Enhancement of noradrenaline release from rat cerebral cortex by neuroleptic drugs

  2004cites this paper
• Central levels of noradrenaline, 3-methoxy-4-hydroxyphenylethyleneglycol and cyclic AMP in the rat after activation of Locus coeruleus neurons: Influence of single and repeated neuroleptic treatment

  2004cites this paper
• Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat

  2004cites this paper
• Effects of chlorpromazine and promazine on the visual aftereffects of tilt and movement

  2004cites this paper
• Anti-dopaminergic and anti-muscarinic effects of dibenzodiazepines

  2004cites this paper
• The role of presynaptic receptors in the release and synthesis of 3H-dopamine by slices of rat striatum

  2004cites this paper
• Proceedings of the British Pharmacological Society

  2004cites this paper
• Interactions of a neuroleptic drug (fluphenazine) with catecholamines in hippocampus

  2004cites this paper
• A comparison of striatal and mesolimbic dopamine function in the rat during 6-month trifluoperazine administration

  2004cites this paper
• Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats

  2004cites this paper
• Dopamine in the CNS I

  2002cites this paper
• Signal Transduction by Dopamine D1 Receptors

  2002cites this paper
• Neurochemical effects of 8-hydroxy-2-di-n-propylamino tetralin in rats treated with haloperidol.

  2002cites this paper
• AUTONOMIC FUNCTIONING IN SCHIZOPHRENIA:

  2001cites this paper
• Superoxide, neuroleptics and the ubiquinone and cytochrome b5 reductases in brain and lymphocytes from normals and schizophrenic patients

  1998cites this paper
• The glutamate receptor genes and schizophrenia : gene expression of antipsychotic drug action and linkage analysis of the genetic susceptibility.

  1997cites this paper
• The relationship between reinforcing effects and in vitro effects of D1 agonists in monkeys.

  1997cites this paper
• Biochemistry of schizophrenia

  1992cites this paper
• Structural changes by sulfoxidation of phenothiazine drugs

  1992cites this paper
• Efficacy and Tolerability of a New Antipsychotic Compound (Risperidone): Results of a Pilot Study

  1991cites this paper
• Molecular Structure and Dynamics of cis(Z)- and trans(E)-Flupenthixol and Clopenthixol

  1991cites this paper
• Three-dimensional structure and molecular dynamics of cis(Z)- and trans(E)-chlorprothixene.

  1991cites this paper
• Catecholamine and arginine vasopressin response to cardiovascular stress induced by lower body negative pressure

  1990cites this paper
• Dopamine receptors of the cockroach salivary gland

  1990cites this paper
• Pilot Clinical Investigation of Risperidone in the Treatment of Psychotic Patients

  1990cites this paper
• The opioid system in neurologic and psychiatric disorders and in their experimental models.

  1990cites this paper
• A Specific Effect of Antipsychotic Drugs on Protein Synthesis in Human Lymphomononuclear Cells

  1990cites this paper
• [The neurochemistry of schizophrenia].

  1989cites this paper
• Dopamine receptors in human brain: autoradiographic distribution of D2 sites.

  1989cites this paper
• The efficacy of the D2 and 5-HT2 antagonist risperidone (R 64,766) in the treatment of chronic psychosis. An open dose-finding study.

  1989cites this paper
• The role of serotonin in schizophrenia.

  1988cites this paper
• Review: D1 dopamine receptor—the search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications

  1987cites this paper
• The Dopamine Hypothesis Survives, but There Must Be a Way Ahead

  1987cites this paper
• Comparison of the acute actions of amine-depleting drugs and dopamine receptor antagonists on dopamine function in the brain in rats.

  1987cites this paper
• Comparative neurobiology of opioids in invertebrates with special attention to senescent alterations.

  1987cites this paper
• Dopamine receptors in brain and periphery.

  1987cites this paper
• Differential down-regulation of D1-stimulated adenylate cyclase activity in rat forebrain after in vivo amphetamine treatments

  1986cites this paper
• Neurobiology of Central D1-Dopamine Receptors

  1986influential citation
• Investigation of the failure of parenterally administered haloperidol to antagonize dopamine released from micropipettes in the caudate

  1986cites this paper
• Evidence for Different States of the Dopamine Dl Receptor: Clozapine and Fluperlapine May Preferentially Label an Adenylate Cyclase‐Coupled State of the Dl Receptor

  1986cites this paper
• Evidence for a functional role of dopamine type-1 (D-1) receptors in the substantia nigra of rats.

  1986cites this paper
• The dopamine D1 receptor: biochemical and behavioral aspects.

  1986cites this paper
• Characterization of dopamine D-1 and D-2 receptors.

  1986cites this paper
• Two syndromes in schizophrenia and the viral hypothesis.

  1986cites this paper
• Schizophrenia: An Overview

  1985cites this paper
• Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis.

  1985cites this paper
• Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis

  1985cites this paper
• 3 – Neuronal Responses to Neuroactive Substances Administered by Push—Pull Perfusion

  1985cites this paper
• Neuroleptic Drugs and Neurotransmitter Receptors

  1985cites this paper
• Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.

  1984cites this paper
• A Comprehensive Method for the Quantitative Determination of Dopamine Receptor Subtypes a

  1984cites this paper
• Specific Receptor‐Mediated Inhibition of Cyclic AMP Synthesis by Dopamine in a Neuroblastoma × Brain Hybrid Cell Line NCB‐20

  1984cites this paper
• Pharmacological characterization of dopamine-sensitive adenylate cyclase in the salivary glands of Locusta migratoria L.

  1984cites this paper
• Quantitative Assay of Dopamine Receptor Subtypes

  1984cites this paper
• Sulpiride: assessment of a pharmacologically and chemically distinct neuroleptic.

  1984cites this paper
• Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to rats.

  1984cites this paper
• Substituted Benzamide Drugs as Selective Agents for Distinguishing Cerebral Dopamine Receptor Sub-types

  1983cites this paper
• BC(DEF) Coordinates 5. Shape-Specific vs. Orientation-Averaged Interactions of Neuroleptics and Other Centrally Acting Drugs: Correlation of Effects in Five in vitro Test Systems

  1983cites this paper
• The classification of dopamine receptors: relationship to radioligand binding.

  1983cites this paper
• CNS Dopamine Receptors

  1983cites this paper
• Mechanisms involved in the blocking effects of pimozide on smooth muscle contraction.

  1983cites this paper
• Radioligand Binding Studies of Dopamine Receptors in the Central Nervous System

  1983cites this paper
• Alterations in cerebral dopamine function caused by administration of cis- or trans-flupenthixol for up to 18 months.

  1983cites this paper
• Multiple dopamine receptors and behavior.

  1983cites this paper
• Adverse effects of anticholinergic medication on positive schizophrenic symptoms

  1983cites this paper
• Potent lipophilic substituted benzamide drugs are not selective D‐1 dopamine receptor antagonists in the rat

  1983cites this paper
• A study of dopamine receptors in the rat central nervous system

  1982cites this paper
• Comparative aspects of opioid-dopamine interaction

  1982cites this paper
• Dopamine receptors in the central nervous system.

  1982cites this paper
• Distribution of effects of haloperidol on energy metabolism in the rat brain.

  1982cites this paper
• Biochemical and pharmacological activities of zetidoline (DL 308‐IT): a new antidopaminergic agent

  1982cites this paper
• Biogenic amine-sensitive adenylate cyclases in insects

  1982cites this paper
• Effect of long term treatment with atypical neuroleptic drugs on beta adrenoceptor binding in rat cerebral cortex and myocardium

  1982cites this paper
• Mapping Functional Alterations in the CNS With [14C]Deoxyglucose

  1982cites this paper
• Regulation of Cellular Excitability by Cyclic Nucleotides

  1982cites this paper
• Neurohumoural and structural changes in schizophrenia: two dimensions of pathology.

  1982cites this paper
• Adaptive changes in catecholamine receptors in the central nervous system.

  1981cites this paper
• The absence of sodium ions does not explain the failure of sulpiride to inhibit, in vitro, rat striatal dopamine‐sensitive adenylate cyclase

  1981cites this paper
• 19 – Neurochemistry of the Olfactory Tubercle

  1981cites this paper
• Dopamine receptors, neuroleptics, and schizophrenia.

  1981cites this paper
• Regulation of adenylate cyclase activity in GH1 cells by chlorpromazine and a heat-stable factor.

  1981cites this paper
• Dopaminergic Mechanisms in the Teleost Retina

  1981cites this paper
• Electrophysiological effects of phencyclidine on rat hippocampal pyramidal neurons.

  1981cites this paper
• Prolonged treatment with the GABA agonist THIP increases dopamine receptor binding more than it changes dopaminergic behaviour in mice

  1981cites this paper
• Characterization of the dopamine stimulated adenylate cyclase in the pedal ganglia ofMytilus edulis: Interactions with etorphine,β-endorphin, DALA, and methionine enkephalin

  1981cites this paper